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Systematic site-directed 
mutagenesis of the Helicobacter 
pylori CagL protein of the Cag type 
IV secretion system identifies novel 
functional domains
Tobias Bönig1,2, Patrick Olbermann1,2, Simon H. Bats1,2, Wolfgang Fischer3,4 & 
Christine Josenhans1,2
The Cag Type IV secretion system, which contributes to inflammation and cancerogenesis during 
chronic infection, is one of the major virulence factors of the bacterial gastric pathogen Helicobacter 
pylori. We have generated and characterized a series of non-marked site-directed chromosomal 
mutants in H. pylori to define domains of unknown function of the essential tip protein CagL of the Cag 
secretion system. Characterizing the CagL mutants, we determined that their function to activate cells 
and transport the effector CagA was reduced to different extents. We identified three novel regions 
of the CagL protein, involved in its structural integrity, its possible interaction with the CagPAI T4SS 
pilus protein CagI, and in its binding to integrins and other host cell ligands. In particular two novel 
variable CagL motifs were involved in integrin binding, TSPSA, and TASLI, which is located opposite of 
its integrin binding motif RGD. We thereby defined functionally important subdomains within the CagL 
structure, which can be used to clarify CagL contributions in the context of other CagPAI proteins or for 
inhibition of the CagT4SS. This structure-function correlation of CagL domains can also be instructive 
for the functional characterization of other potential VirB5 orthologs whose structure is not yet known.
The human pathogen H. pylori colonizes the stomach mucosa of approximately half the world’s population. In 
most cases, infection causes chronic active gastritis but remains largely asymptomatic1. However, the course of 
the disease can also be associated with symptomatic gastritis and the development of gastric and duodenal ulcers2 
and even more severe alterations of the gastric mucosa including malignant host cell transformations such as 
mucosa-associated lymphoid tissue (MALT) lymphoma and gastric adenocarcinoma3. The genome of the higher 
pathogenic H. pylori strains contains a 37 kb genomic island, the cytotoxin associated gene pathogenicity island 
(cagPAI) that plays a crucial role in the outcome of the infection4,5. A subset of genes in this genetically highly 
variable region encodes a type IV secretion system (T4SS), the CagT4SS, which induces the secretion of proin-
flammatory chemotactic cytokines such as interleukin-8 (IL-8) from gastric epithelial cells6,7. The expression 
of a functional CagT4SS mediates a profound proinflammatory response in vivo and in vitro and is thus con-
sidered one of the major virulence and cancerogenic factors of H. pylori. During infection, the pathogen uses 
the CagT4SS to transport the cagPAI-encoded effector protein cytotoxin-associated gene A (CagA) into human 
host cells8. Upon delivery into the target cell cytosol, CagA becomes sequentially tyrosine-phosphorylated at its 
C-terminal EPIYA motifs by different tyrosine kinases and influences cell functions9–11. Several CagA-dependent 
effects on cells and interaction partners have been identified12,13. The presence of the cagPAI and CagA correlates 
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with an increased risk of cancer development in humans14. Studies using transgenic expression of CagA in mice15 
and zebrafish16 earmarked the protein as a bacterial oncoprotein.
The cagPAI-encoded CagT4SS is a multisubunit protein structure that is ancestrally related to the bacterial 
conjugation machinery17,18. The H. pylori cagPAI encodes homologs of most prototypical VirB proteins, including 
a surface-exposed component CagC, discussed as a remote ortholog of the Agrobacterium tumefaciens major pilus 
subunit VirB219,20, the potential VirB5 homolog CagL21, and additional Cag proteins that are essential for proper 
T4SS assembly and function5,18,22–25.
As part of a systematic mutagenesis of the genes of the H. pylori cagPAI, CagL was shown to be essential 
for CagA translocation into host cells and the induction of interleukin-822. CagL exhibits features similar to 
other VirB5 orthologs such as its predicted N-terminal signal peptide, relatively short protein length and its 
hydrophobic profile which shows two hydrophobic peaks at the N- and C-termini, reviewed in21 and previously 
defined as characteristics of the remote VirB5 ortholog TraC26. Furthermore, CagL was localized at the tip of the 
surface-exposed CagT4SS structure and reported to bind to the β subunit of integrins, an important proposed 
host cell receptor for CagL21,27,28. The RGD motif within CagL can serve as a binding sequence for different inte-
grins27,29–32. The important role of β 1 integrin for CagA translocation was again highlighted independently, and 
three additional cagPAI-encoded proteins (CagA, CagY and CagI) were identified as putative β 1 integrin interac-
tion partners33. We and others have previously found that CagL is subject to positive or diversifying selection in 
some of its protein segments5,34,35. Variable amino acids in the N-terminal part of CagL have been postulated to 
be involved in cancerogenesis35,36. These signatures of diversifying selection may be due to different evolutionary 
selection pressures in the human host, such as antibody-derived immune pressure or interactions with variable 
host individuals and host cell receptors.
The central role of CagL in the H. pylori CagT4SS motivated us to perform detailed investigations to iden-
tify novel CagL segments that are crucial for the proper functioning of the CagT4SS. On the basis of previ-
ous results, we hypothesized that predicted loop regions in CagL are likely to harbor novel functional motifs. 
We also hypothesized that integrin interaction may not be the only mechanism mediating CagL cell interac-
tion and CagT4SS-related functions. In this study, we have therefore characterized CagL using a comprehensive 
site-directed mutagenesis strategy introducing short deletions into the protein. One objective was to identify 
amino acid motifs in CagL that could contribute to CagL cell interaction, in an either integrin-dependent or 
integrin-independent manner.
Deletions in several regions of CagL influenced the amounts and subcellular localization of CagL and the 
activity of H. pylori on human gastric epithelial cells. It was possible to distinguish subsets of mutants which 
underwent a complete loss of CagT4SS function, mutants with intermediate phenotypes, and mutants with minor 
functional deficiencies. Taken together, using functional assays, we were able to identify motifs involved in the 
stability and subcellular bacterial transport of CagL, motifs likely involved in the interaction with other CagT4SS 
proteins such as CagI, and a subset of mutants in motifs other than RGD which had moderate functional deficits 
but seem to be involved in the interaction of CagL with integrins or other cellular components.
Results
CagL contains conserved and variable sequence motifs in predicted loop segments. CagL, the 
gene product of HP0539/cagL, is a cagPAI-encoded surface-associated protein27 involved in the induction of IL-8 
secretion and CagA translocation22. In previous studies, we and others have identified the HP0539/cagL gene as 
one of several cagPAI genes to show a signature of diversifying selection, at about 8.9% of its codons (21 of 237 
amino acids (aa))5,35. The CagL structure is composed of largely alpha-helical regions interspersed by potentially 
exposed loops. We have now combined in silico prediction of secondary and tertiary structure with the recently 
published crystal structure37 in order to identify loop regions in CagL and match them with diverse or conserved 
protein segments in different world-wide H. pylori CagL protein variants. Comparing 38 CagL sequences from 
different globally collected H. pylori strains (Supplementary Fig. S1), we identified mainly three regions, aa 26 to 
35, aa 55 to 62 (loop 1), and aa 170 to 175 (loop 4), which showed a larger sequence diversity between strains (for 
details of evolutionary diversifying selection of single amino acids, see also5). We found that most CagL variable 
regions were located within disordered or loop segments that connect the alpha-helical core (Fig. 1A,B)38. The 
prediction that some regions in CagL that are subject to diversifying selection in vivo5 might be surface-exposed is 
also in line with the major surface-exposed segments identified in the CagL structure38. Several other segments of 
the protein were rather conserved in all CagL variants, for instance within loop regions 2 and 3 (Fig. 1B). We have, 
in addition, compared CagL with various representative bacterial VirB5 proteins, of which CagL is a potential 
ortholog, using multiple sequence alignments (Supplementary Fig. S2; Supplementary Methods). Although the 
amino acid identity is low between these potential orthologs (between 15.5% and 28.8%), this approach also iden-
tified disordered segments which appear to be unique for CagL (Supplementary Fig. S1; Supplementary Fig. S2; 
Supplementary Fig. S3).
Comprehensive site-directed mutagenesis of H. pylori CagL in its predicted loop regions. Based 
on the above-mentioned multiple sequence alignments (Supplementary Fig. S1; Supplementary Fig. S2), and the 
CagL crystal structure38 (Fig. 1B), we selected ten short CagL segments, mainly localized in predicted flexible 
protein loops, for site-directed mutagenesis (SDM), in order to delete short motifs of three or five amino acids. 
We anticipated that this approach should facilitate elucidating the role of these regions for the assembly of the 
CagT4SS, as well as for CagL integrin and possibly additional host cell interactions, without being overly disrup-
tive to protein structure. The CagL motifs chosen for SDM included the motifs TSPSA, NNEM, RGD, ELFFI, 
SEDVI, FKTYM, LDQNT, AEQQC, GISDK, and TASLI (Fig. 1A,B). Five of these CagL motifs, TSPSA ELFFI, 
SEDVI, FKTYM and GISDK, are rather conserved in CagL of all analyzed H. pylori strains, and, like the RGD 
motif, are not present in other bacterial VirB5 proteins. A larger extent of H. pylori inter-strain variability was 
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found within the selected CagL segments that are located inside longer loops or disordered regions (loops 1 
and 4; NNEM, LDQNT, AEQQC and TASLI). The SDM was performed by unmarked homologous recombi-
nation of altered cagL alleles from a suicide plasmid into the H. pylori chromosome (Methods) in the highly 
DNA-uptake-competent strain SU25. As an additional control strain, we also constructed a cagL insertion/inac-
tivation mutant in H. pylori (SU2) by allelic exchange mutagenesis, which reproduced the results presented by 
Fischer et al.22. The mutants were first tested for bacterial growth, in order to provide a basis for further inves-
tigations. All mutants showed no growth defects in comparison to the H. pylori SU2 wild type reference strain 
(data not shown). We also performed template-based modelling of the predicted protein structures for the com-
plete set of deletion mutants using the first published CagL crystal structure as template38, in order to anticipate 
severe defects of the short deletions on protein folding or tertiary structure (Supplementary Fig. S4). Some of 
the short deletions were predicted to exert a minor influence on protein fold, for example the TSPSA deletion, 
which affected the tilt of adjacent alpha helices; other deletions were not predicted to influence protein structure 
(Supplementary Fig. S4, see also Discussion).
Differential expression and localization of CagL in chromosomal mutants expressing variant 
CagL proteins. We then further characterized the generated set of isogenic chromosomal unmarked mutants 
expressing variant CagL proteins. Initially, we tested CagL expression (Fig. 2), in order to lay the groundwork for 
assessing functional deficits of the CagT4SS associated with the short deletion mutants.
Some of the motif deletion mutants generated by site-directed mutagenesis showed striking differences in 
CagL expression levels. In particular, five mutants (Δ ELFFI, Δ SEDVI, Δ FKTYM, Δ LDQNT, Δ GISDK) stood 
out by a strong reduction in overall CagL (Fig. 2). The most substantial reduction was observed in the latter two 
mutants. Interestingly, the decrease of CagL in these mutants correlated with a strongly diminished detection of 
CagI, but no reduction of CagH (Fig. 2; see below). In four of the motif deletion mutants, CagI was surprisingly 
Figure 1. Secondary and tertiary structural prediction of H. pylori CagL (strain 26695); the selection of ten 
short motifs for generating deletion mutants is indicated with regard to the recently solved CagL crystal 
structure. (A) Placement of the ten motif deletion mutants within the secondary structure of CagL. Secondary 
structure prediction was performed using Jpred (www.compbio.dundee.ac.uk/jpred). Alpha helices are indicated 
by red symbols, beta sheets are indicated by blue symbols. Only the structured regions of confidence score  
≥ 1 of the Jpred prediction are indicated by symbols below the sequence. SP designates a predicted leader peptide 
which probably serves to transport CagL to the periplasm. (B) Placement of the ten motif deletion mutants in 
the CagL crystal structure (pdb: 3zcj_chainA38), which was imaged in ribbon mode by Yasara (www.yasara.
org). Motif deletion mutants along the 2D and 3D structure are indicated in blue (2D) and in different colors 
(3D structure; pink, turqoise, red, purple, yellow) contrasting to the backbone shown in royal blue. The probably 
disordered regions (“loops”) within CagL which correspond to predicted loop regions in a CagL structural 
prediction (not shown) are indicated and numbered as loop 1 through loop 4 in B (also indicated as loops with 
the same numbering in Supplementary Fig. S2). The TSPSA motif was not structurally resolved in the crystal 
(3D) structure pdb: 3zcj_chainA and therefore is not indicated in B (loop 1).
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reduced to similar levels as in a cagL knock-out mutant, which we included as a negative control (Fig. 2). CagI 
was even no longer detectable at all in whole cell lysates of the Δ LDQNT motif mutant (Fig. 2), in contrast to the 
cagL knock-out mutant, which still had detectable levels of CagI. Three deletion mutants, Δ RGD, Δ AEQQC, and 
Δ TASLI, displayed intermediately reduced CagL amounts by about 40% to 50% (Fig. 2).
For detecting the subcellular localization of wild type and mutant CagL proteins, H. pylori bacteria were 
separated into outer (O), soluble (S) and insoluble (I) fractions (Methods). Representative results of Western 
blot analyses are depicted in Supplementary Fig. S5 (one of two tested mutant clones with equivalent results are 
shown for each deletion). In bacterial cell fractions of the H. pylori SU2 wild type, we detected CagL in all three 
fractions. The largest amounts of CagL were localized in the insoluble fractions of wild type bacteria (predicted 
to be enriched in membrane-associated proteins). No CagL was detected in the isogenic cagL insertion mutant 
(SU2 cagL::aphA3). The comparative analyses of CagL localization in bacterial fractions between the various 
chromosomal deletion mutants also revealed differences in CagL localization (Supplementary Fig. S5; Table 1). 
Interestingly, in one of the five mutants which showed a strong overall CagL reduction in lysates, SU2 CagLΔLDQNT, 
which is located in loop 3 (Fig. 1B), CagL was, in addition, not detected anymore in the soluble nor in the outer 
fractions (Supplementary Fig. S5). In the mutant deleted for motif ELFFI, a motif which is located within the 
hydrophobic core of the CagL structure (Fig. 1B)38, small amounts of CagL were still detectable in all fractions 
(Supplementary Fig. S5), indicating that the membrane transport of CagL is not diminished in this mutant despite 
its reduced CagL amounts. Three of the five strongly expression-deficient mutant strains, SU2 CagLΔSEDVI, SU2 
CagLΔFKTYM at the edge of the α 2 helix, and SU2 CagLΔGISDK in loop 3, exhibited a detectably reduced CagL 
expression in all three fractions, although they produced more CagL than the latter two mutants. The fraction-
ation pattern for SU2 CagLΔGISDK (loop 3) also indicated a CagL transport defect (Supplementary Fig. S5), since 
Figure 2. Quantification of CagL and other Cag proteins in whole cell lysates of several isogenic chromosomal 
CagL motif deletion mutants (strain SU2). Bacteria were lysed by sonication (whole cell lysates). Equal protein 
amounts of each sample (10 μ g) were separated on 11.5% SDS gels followed by Western blotting. Proteins CagL, 
CagI, CagH, Hp antigen, CagA were detected using specific antisera (rabbit α -CagL, 1:20,000; rabbit α -CagI, 1:5,000; 
rabbit α -CagH, 1:5,000; rabbit α -H. pylori, DAKO, 1:2,500; rabbit α -Hp-CagA, 1:10,000), and matching secondary 
antisera. CagL, CagI, CagH and CagA amounts in each strain were quantitated by densitometry using ImageJ56  
















SU2 wt + + + + + + + + + + + + + + 
cagL::aphA3 − − + + + + + − n.d.
CagLΔTSPSA + + + + + + + + + + + + + + 
CagLΔNNEM + + + + + + + + + + + + + + 
CagLΔRGD + + + + + + + + + + + + + + 
CagLΔELFFI + + + + + + + + − 
CagLΔSEDVI + + + + + + + + + + 
CagLΔFKTYM + + + + + + + + − 
CagLΔLDQNT − − − + + + + − n.d.
CagLΔAEQQC + + + + + + + + + + + + 
CagLΔGISDK − − + + + + + + n.d.
CagLΔTASLI +(+) + + + + + + + + + + + + 
CagLΔRGDΔTASLI − + + + + + + + + + 
CagLΔTSPSAΔRGD − + + + + + + + + + + 
CagLT170K + + + + + + + + + + + + 
Table 1. Comparative analyses of various chromosomal HP0539/cagL deletion mutants. The plus and 
minus signs in each column indicate: [+ + ], [+(+)] normal to slight reduction, [+ ] clear reduction, and [− ] 
strong reduction of the respective protein or function (column header) in comparison with the parental strain 
(reference, SU2 wild type [wt]). aThe short term “CagL secretion” indicates that CagL was detected in the outer 
fraction of the bacteria which includes surface-associated material; CagL has been detected before by others on 
the bacterial surface27,24. n.d. = below detection level.
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this mutant was the only one in which CagL was still detectable in the insoluble fraction but not in the outer 
fraction. In two chromosomal deletion mutants, SU2 CagLΔTSPSA and SU2 CagLΔNNEM, we did not note any con-
siderable changes in CagL amounts and CagL distribution in the three analyzed fractions compared to the paren-
tal strain (Table 1; Supplementary Fig. S5). SU2 CagLΔRGD and CagLΔTASLI mutants showed slight changes in all 
fractions. Approaches to directly detect CagL on the surface of intact bacteria in microscopy using antibodies, 
which we carried out in order to refine our localization analyses in the different mutants, were not successful (data 
not shown).
H. pylori CagL deletion mutant strains exhibited distinct differences in the activation of human 
gastric epithelial cells and in CagA translocation. During the infection, cagPAI-positive H. pylori 
strains induce the secretion of IL-839 and translocate CagA into host cells8,12,40. For further characterization of the 
comprehensive set of deletion mutant strains expressing different CagL variants, we analyzed these properties of 
all mutant bacteria in cell coincubation experiments (AGS gastric epithelial cells) and CagA translocation assays, 
in order to reveal functional deficiencies of the CagT4SS in the respective mutants. While the cells secreted IL-8 
into the supernatant in response to coculture with H. pylori wild type (Fig. 3; Table 1), all tested motif mutants 
exhibited reductions in IL-8 induction in comparison to the parental strain. Similar phenotypes were shown 
for two separate clones each of every CagL short deletion mutant (Fig. 3). The CagL-negative control mutant 
(SU2 cagL::km) led to a strongly reduced IL-8 release, below 20% of the wild type, in confirmation of previous 
data22. Mutant strains SU2 CagLΔNNEM, SU2 CagLΔSEDVI, SU2 CagLΔAEQQC, SU2 CagLΔTASLI reached values of 
approximately 80% of the wild type strain, reflecting moderate but significant impairments in the induction 
of cellular IL-8 (Fig. 3). Mutant strains SU2 CagLΔELFFI and, in particular, SU2 CagLΔFKTYM, which possessed 
an overall strongly reduced amount of CagL in all cellular fractions, displayed an intermediate phenotype with 
significantly reduced values between 50% and 60% of wild type IL-8 values. The two mutants SU2 CagLΔLDQNT 
and SU2 CagLΔGISDK, which both showed strongly diminished amounts of CagL overall and in the insoluble and 
outer fractions, had the most severely impaired cell activation phenotypes with reduced IL-8 induction values 
of around 10% of the wild type values in the case of SU2 CagLΔLDQNT (Fig. 3, Table 1). These latter values were 
even lower than in the CagL-deficient negative control. SU2 CagLΔRGD induced moderately diminished cellu-
lar IL-8 values of around 70% compared to the SU2 wild type. When we combined moderately IL-8 deficient 
motif deletion mutants to generate double mutants (CagLΔTSPSAΔRGD, CagLΔRGDΔTASLI), we determined a stronger 
(additive) defect in IL-8 secretion than for the respective single mutants Δ TSPSA and Δ TASLI (Fig. 4). However 
CagLΔTSPSAΔRGD was not significantly different from CagLΔRGD. Next, for testing a second known functionality 
of the cagPAI T4SS, we examined the translocation of the CagA effector protein into host cells by coculturing 
H. pylori SU2 wild type and all cagL SDM mutant strains (two clones of each strain) with AGS cells. CagA trans-
location and intracellular phosphorylation, determined as the amount of pTyr-CagA upon cell coincubation, are 
completely dependent upon the presence of CagL22. The results are summarized in Table 1. The SU2 CagLΔNNEM 
mutants displayed no reduced CagA translocation (densitometry quantitation normalized to the wild type used 
in the respective experiments; Methods). In SU2 CagLΔRGD, CagLΔTSPSA and SU2 CagLΔTASLI mutants, that had 
a moderate deficiency in IL-8 secretion, we noted a comparable reduction of CagA translocation to about 55 to 
Figure 3. IL-8 induction capacity of site-directed short deletion mutants in CagL in comparison to the 
parental strain H. pylori SU2. AGS cells were infected for 22 h (MOI = 50) with several isogenic chromosomal 
HP0539/cagL mutants as indicated in the figure. Culture supernatants of coincubated AGS cells were tested for 
IL-8 by ELISA. The level of IL-8 secretion induced by contact with the SU2 reference strain was set to 100%. The 
corresponding values of the HP0539/cagL motif mutants are depicted in percent in relation to wild-type levels. 
Results from two independently generated and validated clones are depicted for each motif deletion mutant. The 
data shown are results (mean and SD) from triplicate measurements of at least four independent experiments. 
Significance of differences in comparison to the parental strain was calculated by student’s t-test shown as black 
asterisks above each bar: ***p < 0.01; **p < 0.02; *p < 0.05. The plus and minus signs at the right side of the 
figure indicate: [+ + ] normal to slight reduction, [+ ] clear reduction, and [− ] strong reduction.
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70% of the parental strain (Supplementary Fig. S6). SU2 CagLΔELFFI and SU2 CagLΔFKTYM, which displayed an 
intermediate phenotype in CagL expression levels, with reduced CagL in the outer bacterial fraction, and inter-
mediate IL-8 induction, showed a strongly reduced (< 10% pTyr-CagA) CagA translocation phenotype, while 
the mutants deleted in the interspersed motifs SEDVI and AEQQC were considerably less deficient (ca. 30% 
pTyr-CagA) in comparison to the wild type (Supplementary Fig. S6). We did not detect any pTyr-CagA at all in 
AGS cells co-cultured with SU2 CagLΔLDQNT and SU2 CagLΔGISDK (Supplementary Fig. S6), both located in loop 
3 and which had strongly reduced CagL and no detectable CagL in the outer fractions.
H. pylori CagL motif mutants influence CagI amounts and CagI localization in subcellular 
bacterial fractions to a different extent, but have no major influence on CagA, CagH and 
CagY. In a recent study, three additional cagPAI-encoded proteins (CagA, CagI, CagY) have been identified 
which, in addition to CagL, can interact with host cell integrins33. CagL, CagI and CagY might thus jointly con-
tribute to CagA translocation. Furthermore, several studies demonstrated that CagI and CagH are two other 
essential components of the Cag T4SS that, jointly and in close interaction with CagL, might form a sub-complex 
at the surface of the bacteria24,25. We therefore tested whether CagL amounts in our set of motif deletion mutants 
influenced the amounts of CagA, CagY, CagI, or CagH, which might help explain a decrease in CagT4SS function.
We did not detect a major influence in bacterial lysates of all H. pylori CagL motif deletion mutants on over-
all CagA amounts (+ /− 13% differences in normalized band intensity detected by densitometry; Fig. 2), or on 
the distribution of CagA in the three tested subcellular bacterial fractions (Supplementary Fig. S5; and data not 
shown). CagY amounts and localization were also not changed in any of the mutants (data not shown).
While we detected CagI to varying amounts in the motif deletion mutants (Fig. 2; Supplementary Fig. S7; 
and see above), in most mutants directly proportional to the amounts of CagL, the mutations did not have a 
major influence on CagH amounts (maximal deviation from the wild type in densitometry of approximately 
25%; Fig. 2; Supplementary Fig. S7). In the fractionation experiments, we detected CagI mainly in the outer 
and insoluble fractions in the H. pylori SU2 parental strain, with a minor portion present in the soluble fraction 
(Supplementary Fig. S5). The negative control, cagL insertion mutant (SU2 cagL::km), exhibited strongly reduced 
CagI amounts in both the outer and the insoluble fractions. Interestingly, CagI showed, in addition, a slight molec-
ular mass shift in the absence of CagL (Supplementary Fig. S5). Fractionation analyses of the cagL motif mutants 
revealed differential effects of the mutants on CagI localization, depending on the site of CagL motif deletion: 
deletion mutants in the hydrophobic CagL region (α 2 and adjacent loop region 2; Fig. 1B), SU2 CagLΔELFFI and 
SU2 CagLΔFKTYM, that had already exhibited overall reduced CagL and CagI levels (Fig. 2), also revealed that CagI 
levels were decreased in all fractions (Supplementary Fig. S5). However, while remarkably in the SU2 CagLΔELFFI 
mutant, CagI was not detected in the bacterial outer and soluble fractions, SU2 CagLΔFKTYM still showed, albeit 
reduced, CagI amounts in the outer fraction. Concerning CagL motif deletions in loop region 3 (Fig. 1B), which 
had the most substantial loss of CagL, CagI was most strongly decreased in all analyzed fractions (most notably 
in the insoluble fraction) in mutant strain SU2 CagLΔLDQNT, which exhibited strongly impaired amounts and 
subcellular distribution of CagL and a complete deficiency to activate AGS cells. In the same loop region, adjacent 
Figure 4. IL-8 induction capacity of selected site-directed double motif deletion mutants and single amino 
acid substitutions in CagL in comparison to the parental strain H. pylori SU2. AGS cells were infected 
for 22 h (MOI = 50) with isogenic chromosomal HP0539/cagL mutants as indicated. Culture supernatants 
of coincubated AGS cells were tested for IL-8 by ELISA. The level of IL-8 secretion induced by contact with 
the SU2 parental strain (wt) was set to 100%, and corresponding percent values of the cagL motif mutants are 
depicted. For each mutant, results were obtained from two independently generated and validated clones. The 
data shown are results (mean and SD) from triplicate measurements of at least four independent experiments. 
Significance of differences towards the parental strain was calculated by student’s t-test shown as black asterisks 
above each bar: ***p < 0.01; **p < 0.02; *p < 0.05. Plus and minus signs at the right side of the figure indicate 
normal to slight reduction [+ + ], clear reduction [+ ], and strong reduction [− ].
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mutant SU2 CagLΔAEQQC also showed overall reduced CagI, despite having only slightly reduced CagL. In the 
last mutant of the same loop, SU2 CagLΔGISDK, despite the remarkably CagL-deficient phenotype of this mutant 
(Fig. 2), CagI was still detected, however in moderately reduced amounts, in all fractions (Supplementary Fig. S5; 
Table 1). This suggests a priority of CagI and partial uncoupling of CagL and CagI in all mutants in loop 3. The 
chromosomal SU2 CagLΔRGD mutant did not show any remarkable change in CagI distribution compared to the 
parent (Supplementary Fig. S5). The three remaining CagL motif mutants did not show a strong effect on CagI 
amounts or localization (Fig. 3; Table 1; Supplementary Fig. S7).
Differential binding of purified CagL variants to integrins and gastric epithelial cells. As shown 
above, several H. pylori motif deletion variants in CagL revealed a significantly deficient phenotype in cell activa-
tion assays, while the amounts of CagL or CagI seemed not altered. This suggested that these mutated segments 
fulfil a function in host cell interaction. In particular, the Δ TSPSA and Δ TASLI motif deletion mutants fell into 
this category, indicating a functional deficiency of the protein combined with structural integrity. In addition, the 
two motifs are relevant to the positioning of the RGD motif and might influence integrin binding: the first motif 
(TSPSA) is located in the disordered region between the α 1 and α 2 helices (loop 1) and may therefore impact on 
the positioning of the two helices with respect to each other32 (Supplementary Fig. S4); the second motif (TASLI) 
is located between helices α 5 and α 6 (loop 4) directly opposite the RGD motif (Fig. 1B) and may influence 
RGD-dependent binding directly or indirectly. This encouraged the hypothesis that both these motifs may act in 
concert with the RGD motif on cells. In order to reveal a functional role and potential redundancy of some of these 
motifs with regard to cell interaction, we established binding assays (ELISA-like assays) in a multi-well format to 
determine the interaction of purified CagL variants with integrins and human gastric epithelial cells (Methods). 
We recombinantly expressed and natively purified CagL wild type protein and selected CagL motif variants in a 
two-step procedure to larger than 98% homogeneity (Supplementary Fig. S8). In addition to wild type protein, 
we chose the CagLΔRGD motif variant as a control for these assays, since this motif was previously reported to 
be involved in integrin binding27,29,32,41. We also added the CagLΔTASLI, CagLΔTSPSA, and the CagLΔRGDΔTASLI and 
CagLΔRGDΔTSPSA double motif deletions to the tested panel of purified CagL proteins (Supplementary Fig. S8). We 
first compared wild type CagL and the other CagL motif variants for integrin binding. CagL integrin binding was 
concentration-dependent (Fig. 5). While the CagLΔRGD motif mutant, as expected, had a significantly reduced 
binding phenotype to various integrins in comparison to wild type CagL (< 50%) (Fig. 5), we determined an even 
stronger reduction of integrin binding for the CagLΔTASLI (< 10%) and CagLΔRGDΔTASLI (< 36%) variants (Fig. 5). 
Interestingly, the single CagLΔTASLI variant already showed a strongly deficient phenotype, even less binding than 
the double-motif-deficient protein CagLΔRGDΔTASLI. The TASLI motif therefore seemed to contribute to integrin 
interaction. The polar threonine residue T170 of TASLI is located directly opposite the RGD aspartate D78 in the 
CagL structure, suggesting a functional interaction of both residues. In order to elucidate its relevance for CagL 
integrin binding, we constructed a single CagL substitution mutant, T170K, replacing threonine 170 with lysine, 
which results in altered physicochemical properties at this site (K170 being a potentially positively charged amino 
acid with a predicted local pKa between 7 and 8 (Methods)). The T170K mutant, when expressed chromosomally 
in H. pylori, had a slight but significant effect (reduction by about 20%; Fig. 4), similarly to the Δ TASLI mutant, 
on IL-8 secretion, but did not lead to a significant reduction in CagA translocation when compared to the paren-
tal reference strain (Supplementary Fig. S6). When we tested the recombinantly purified CagL T170K variant for 
integrin binding, it also showed a significant binding deficiency at the tested conditions (Fig. 5). A CagL T170A 
single substitution mutant of threonine with non-charged alanine also displayed a decrease in integrin interac-
tion, however less pronounced than the T170K mutant (data not shown). A CagLΔTSPSA mutant showed a strongly 
reduced binding phenotype to integrins, lower than the CagLΔRGD and similar to the CagLΔTASLI mutant (Fig. 5). 
The CagLΔRGDΔTSPSA double deletion mutant did not mediate a further reduced integrin interaction in compar-
ison to CagLΔRGD. With regard to cell activation by live bacteria, the SU2 CagLΔRGDΔTASLI double motif mutants 
led to a more strongly diminished IL-8 secretion upon coincubation with AGS cells than the single CagLΔRGD, 
CagLΔTASLI and CagLΔTSPSA mutants (to about 60% of the wild type levels; Fig. 4), while the CagLΔRGDΔTSPSA 
mutant was inducing IL-8 secretion at the same level as CagLΔRGD. This result indicated a very minor involvement 
of the TSPSA motif in IL-8 induction in the absence of RGD.
In a similar assay, we assessed the binding of purified CagLwt protein variants to fixed AGS cells. CagLΔRGD 
resulted in significantly reduced binding to cells, again to about 50% of CagLwt. CagLΔTSPSA (34% of wild type 
protein) and CagLΔTASLI (15% of wild type protein) mutants bound significantly less well to cells than the wild 
type protein and the CagLΔRGD mutant protein. However, both double deletion proteins, CagLΔRGDΔTSPSA and 
CagLΔRGDΔTASLI, showed no further reduction in AGS cell binding in comparison to the CagLΔRGD single motif 
mutant (Fig. 6). In contrast, the purified CagLΔTSPSAΔRGD, CagLΔRGDΔTASLI and CagLT170K mutated proteins bound 
significantly better to cells than the CagLΔRGD single mutant. This suggested that the TASLI motif contributes 
to integrin binding, while the same motif, probably in a conformation-dependent manner, is not required for 
efficient CagL cell binding in the presence of other potential cellular binding partners (Discussion). Under con-
ditions of reduced pH (≤ 6) during cell binding, we determined an even more increased binding of CagLT170K, 
CagLΔTASLI and CagLΔRGDΔTASLI proteins to AGS cells in comparison to the wild type protein (data not shown; see 
Discussion).
Discussion
CagL, which was described as a possible VirB5 ortholog of the H. pylori CagT4SS21, is essential for the function of 
the CagT4SS22. CagL is a secreted protein of the Cag apparatus which stays at the bacterial surface, where it can 
interact with cellular factors, unlocking the functionality of the CagT4SS24,27. One such established cell attach-
ment factor is human integrin. Integrin can be bound by the RGD motif in CagL27,29,32 and RGD-independently 
by other cagPAI proteins33, and is involved in CagA translocation. Based on 3D structural modelling of CagL loop 
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regions, confirmed by several recently clarified crystal structure variants of CagL32,37,38,42, the analysis of global 
H. pylori inter-strain variation, and the comparison of H. pylori CagL with other potential bacterial orthologs, we 
have formed the hypothesis that unique loop regions in CagL harbor as yet unknown functions. We have there-
fore aimed in the present study at defining novel CagL motifs which can be involved in functions of CagL with 
regard to the CagT4SS and host cell interaction.
Taken together, we have confirmed the hypothesis that CagL-specific loop regions, in particular 
sequence-variable ones, can exert novel functions with respect to CagL and the host interaction of Cag T4SS. 
Through detailed analysis of a set of ten chromosomal CagL motif deletion mutants in H. pylori, we found that 
several motifs, localized predominantly in disordered regions, play novel roles in maintaining distinct CagL pro-
tein functionalities. We have pinpointed amino acids at the edge of helix α 2 (CagL core region and loop 2) and 
a large loop region between the α 3 and α 5 helices (loop 3) that impact on CagL amounts. The same segments 
also codetermine CagI amounts and are possibly involved in CagL interaction with the Cag pilus protein CagI. 
We have also found that two novel strain-variable CagL loop motifs, TSPSA5,34,35,36 in loop 1, and TASLI (aa 170 
to 175 in loop 4), are involved in determining the strength of integrin interaction (TSPSA and TASLI), or mod-
ulate CagL cell binding (TASLI). The first of these latter CagL segments has been previously highlighted: several 
research groups have determined an association between amino acid polymorphisms in this segment adjacent to 
TSPSA (in particular in amino acids 58 and 59) and the cancer risk of infected patients34,36,43. There is conflicting 
evidence on the role of these amino acids, and the pathological association of polymorphisms has not been caus-
ally confirmed yet.
In the present study, we have functionally analyzed those ten CagL motif deletion mutants for CagL integrity, 
bacterial localization and host cell interaction. Possibly related to CagL protein integrity, we have identified three 
motifs at the edge of helix α 2 which strongly contribute to overall amounts of CagL in the cell but hardly impair 
CagL subcellular localization. We propose that these three motifs, ELFFI, SEDVI and FKTYM, mainly contribute 
to CagL stability and integrity (Fig. 1B; Supplementary Fig S3). This hypothesis, which was raised earlier by oth-
ers31 is supported by the CagL crystal structure that revealed that these motifs are located within the hydrophobic 
Figure 5. Differential binding of different site-directed CagL motif mutants to recombinant human integrins 
α5β1, αvβ5 and αvβ6. Highly purified native CagL motif mutant proteins (ng amounts, as  indicated) were 
incubated in microwell plates coated with recombinant human integrin heterodimers (R&D Systems) for 3 h 
(followed by extensive washing) and quantitated by an ELISA-like sandwich method using anti-CagL antibody 
(Methods). The results are depicted as relative values in comparison to the purified CagL wild type control, which 
was set to 100% (Methods). In (A), the concentration-dependent binding of CagL wild type to integrin is shown;  
in (B,C,D), the binding of wild type CagL and different CagL mutants (10 ng each) to different integrin variants (α 5β 1,  
α vβ 5, α vβ 6, respectively) is depicted. A significant loss of binding of the mutated CagL variants in comparison to 
the wild type was quantitated for each integrin type. In panel B, mean values and significances of differences towards 
CagL wild type binding were calculated by student’s t-test (two-tailed, unpaired) from the mean and SD of three 
independently performed experiments, summarizing seven data points in total for each protein, and are shown 
as black asterisks above each bar: ***p < 0.01. Upper row of asterisks in (B) significance of differences between 
CagLΔRGD mutant and other mutants, respectively, calculated on the basis of the same experiments. In panels (C)  
and (D), mean and p values from technical duplicates of one experiment, respectively, are depicted. n.s. = not 
significant.
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CagL core, which is presumably required for proper protein folding and stability31,38. Moreover, the deletions of 
either the ELFFI or FKTYM motifs contributed to a directly proportionate loss of the CagL-interacting Cag pilus 
protein CagI24,25, which may offer additional explanations for the strong loss-of-function phenotype of these 
variants in host cell interaction (IL-8 secretion and CagA translocation). CagL and CagI have previously been 
shown to directly interact with each other and to contribute jointly to the formation of Cag-dependent pili-like 
structures upon host cell contact24,25. The loss of these structurally important CagL motifs may lead to misfolding 
of CagL in the bacterial cytoplasm or periplasm. Hence, this change may contribute to low amounts of persisting 
CagL protein and also bring about the loss of the partner protein CagI.
Deletion of either of two other motifs of a second novel functional category (LDQNT and GISDK in CagL 
loop 3) led to an even stronger reduction in CagL amounts in H. pylori, accompanied by an almost total loss 
of CagL in the soluble and outer fractions. H. pylori mutants carrying either of these two motif deletions had 
severely impaired phenotypes for IL-8 induction and, in particular, an almost complete loss of CagA transloca-
tion. The CagLΔGISDK mutant, while maintaining some CagI in all fractions, albeit at low levels, had a transport 
defect of CagL to the outer fraction, while the CagLΔLDQNT mutant had a deficiency of CagI in the insoluble frac-
tion. We therefore speculate that those loop 3 motifs may involve a direct interaction of this CagL protein domain 
with CagI24,25, possibly during membrane passage, and assist in the secretion pathway of CagL to the bacterial 
surface. It is not excluded that, in addition, the lack of LDQNT and GISDK motifs leads to misfolding and some 
degradation of both CagL and CagI. Deletion of the loop 3 interspersed motif AEQQC reduced CagI but not 
CagL amounts, offering a further argument that this segment might be involved in CagL-CagI cooperation.
In general, a reduction in CagL amounts led to a proportionate reduction of CagT4SS function, even if the loss 
was relatively minor and CagL still localized correctly, for instance in the mutants CagLΔELFFI, CagLΔSEDVI and 
CagLΔFKTYM. With two exceptions, CagLΔSEDVI and CagLΔAEQQC bacteria, both CagI amounts and T4SS activities 
in the mutants appeared to be directly proportionate to CagL amounts.
Furthermore, we have identified a set of other motifs of a third novel functional category in CagL which did 
not lead to a major loss of CagL expression nor impaired subcellular localization of CagL and its interacting 
proteins, and exhibited a moderate but significant functional reduction of the CagT4SS in the context of live 
bacteria and AGS cell coculture. We considered these motifs particularly interesting, since they might be involved 
in modulating CagL and cagPAI activities with respect to cell interaction. Two of these motifs, the well-studied 
RGD motif (a known integrin binder27,28,44) and TASLI, are located closely adjacent and opposite each other in the 
CagL structure37. Mutations in the CagL RGD motif revealed before that it is involved in inducing cell signalling 
and NF-κ B activation via integrins, even in the absence of CagA translocation44. Purified CagL deletion variants 
Δ RGD and Δ TASLI independently had a clearly deficient phenotype in integrin binding. Although expected for 
the RGD motif deletion, the Δ TASLI deletion surprisingly showed an even more drastic loss of native integrin 
binding with all tested integrins. The RGD- and TASLI-dependent loss of CagL binding to integrins was particu-
larly severe for integrin α Vβ 6, which has recently been shown to possess a particularly high affinity to CagL28. We 
therefore propose that the TASLI motif is a novel trait that contributes to integrin binding independently of RGD. 
In addition to an independent function, it may also contribute, presumably by stabilizing the conformation of 
Figure 6. Differential binding of site-directed CagL mutants to AGS human gastric epithelial cells. Highly 
purified native CagL variants (ng amounts, as indicated) were incubated in microwell plates containing fixed 
adherent AGS cells for 3 h, followed by extensive washing, and quantitated by an ELISA-like method using 
anti-CagL antibody (Methods). The results are depicted as relative values in comparison to the CagL wild type 
control, which was set to 100%. Cell binding by different CagL mutants (10 ng each of highly pure protein) in 
comparison to wild type CagL is shown. Significances of differences to CagL wild type binding were calculated 
by student’s t-test (two-tailed, unpaired) from the mean values and SDs of three independently performed 
experiments, summarizing six data points in total, and are shown as black asterisks above each bar: ***p < 0.01; 
*p < 0.05. Upper row of asterisks: significance of differences between CagLΔRGD mutant and other mutants, 
calculated on the basis of the same experiments. n.s. = not significant.
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the opposing RGD and TASLI regions within the CagL tertiary structure, to better positioning the RGD motif for 
host cell integrin binding. Additional assays (own unpublished data) revealed that the phenotype of integrin and 
cell binding of CagL was also influenced by the composition of the blocking buffer, in particular by the presence of 
serum proteins. Since the integrin-binding protein collagen45 was able to partially mimick this serum effect (own 
unpublished data), which was lost for the Δ TASLI mutant, we currently propose that the TASLI motif contributes 
indirectly to the binding of integrins in the presence of integrin-binding serum protein. Another motif deletion 
reducing the binding of purified CagL to integrins was TSPSA in loop 1. Our results suggest that this effect is not 
direct, but possibly introduces a conformational change that may alter the positioning of CagL alpha helix α 2. 
Template-based structural modelling of the CagL TSPSA deletion mutant also suggested a slight repositioning of 
the α 2 helix with regard to α 1 and the intrinsic turn of helix α 2. In line with this, recent structural data32,42 sup-
port the hypothesis that the position of α 2 and the relative orientation of helix α 2 versus helix α 1 are important 
for the RGD motif to be in the correct orientation to optimally interact with integrins. This conformational flexi-
bility impacts on CagL integrin binding, in particular at low pH as recently demonstrated32. Another RGD helper 
sequence (RHS), the amino acid motif “FEANE”, was reported which influences the binding of the neighboring 
RGD motif to integrins30. We did not include this RHS in our analyses, since it is located in the stabilizing hydro-
phobic core region (α 2) of CagL37 and is not subject to diversifying selection in the CagL sequence5. The H. pylori 
strain variability in and downstream of the TSPSA region, with short deletions of several amino acids prevalent in 
different geographical isolates5 (Supplementary Fig. S1) also invites the hypothesis that, with regard to host inter-
actions, evolutionary selection might have modulated CagL structure towards an optimized function of CagL in 
the respective host ethnicities. This hypothesis cannot easily be verified in vitro. Transferring certain mutations in 
this region to a reference strain and testing these on host cells as has in part been done already46 might offer more 
clues as to whether these variations modulate the interaction of CagL with host cells. In addition, strain-specific 
structural differences in CagL variants, for example disulphide bridges, which can confer higher stability at lower 
pH42 are suggestive to be the result of functionally diversifying evolution.
While we determined a strongly reduced phenotype in CagL integrin binding of the CagLΔTASLI and Δ RGDΔ 
TASLI double mutants, the effect of mutated live bacteria on CagA translocation and IL-8 secretion, even if the 
two motifs were deleted in combination, was relatively minor (max. 40% inhibition for the Δ RGDΔ TASLI dou-
ble deletion mutant). Notably, while a significant reduction in binding of purified CagL to fixed AGS cells was 
shown for the Δ RGD and even more so for the Δ TASLI deletion, the combined deletion of RGD and TASLI had 
a close to wild type phenotype for CagL binding to gastric epithelial cells. This effect was even enhanced at lower 
pH (own unpublished data). These findings also corroborated earlier reports33,30 that the RGD motif is not essen-
tial for CagA translocation and IL-8 induction. This indicates that these effects can occur by integrin-independent 
interaction of CagL with cells. It may also be fair to speculate, that in contrast, if integrin binding might be absent 
by cell type characteristics, or if a pH shift, involving CagL conformational change, might diminish integrin bind-
ing32, other cellular factors might come into play for CagL binding and T4SS functionality. This also supports the 
idea that, in addition to dedicated integrin binding segments, other CagL sections are likely involved in interac-
tion with the cell surface and cell activation for T4SS effector translocation.
Indeed, alternative CagL crystal structures obtained at a pH below 5 demonstrated that, in addition to helices 
α 1 and α 2, helices α 5 and α 6 may undergo a conformational change28,32. The disordered region between helix α 5 
and α 6 apparently can convert to an extended helix in the place of the antiparallel α 5 and α 6 fold28,32. The TASLI 
motif is localized in the extended conformation in the center of the extended helix with a different tilt, and also 
the orientation of the TASLI motif towards the RGD motif in the adjacent helix α 2 will be changed. While Barden 
et al. showed that T170 and D78 of the two structurally opposing motifs (RGD, TASLI) are positioned opposite 
each other with a short distance at close to neutral pH37, the crystal structures obtained at lower pH28,32 reveal 
a conformational separation of the two helices and hence of the two motifs. Our results appear to indicate that 
upon the joint deletion of TASLI and RGD, CagL may undergo a conformational change. This still needs to be 
confirmed by biophysical methods in the future. Assuming that these deletions bolster an elongated conformation 
of helices α 5 and α 6, they may contribute to a stronger CagL cell binding, while possibly diminishing integrin 
binding. A similar phenotype as for the Δ RGDΔ TASLI mutant was also observed when T170 in TASLI was 
mutated to lysine. This predicted potentially pH-sensitive mutation (Methods), which might affect the electro-
static interaction with the opposite D78 residue, might increase the propensity of the α 5 and α 6 helices to flip to 
an extended conformation. Altogether, these results encourage the hypothesis that a novel integrin-independent 
cell-binding patch within CagL is exposed upon the structural elongation of the α 5 and α 6 helices.
Only two proposed VirB5 proteins of T4SS have been structurally characterized so far, TraC, which is a remote 
ortholog from a DNA conjugation system in Escherichia coli26 and CagL37,42,32. While TraC26 and CagL37 are not 
very similar in structure, they exhibit common features such as a high content in alpha helices, arranged in an 
antiparallel conformation. In both these proteins, these alpha helices are interspersed with disordered regions, 
whose functional importance is underlined by our current characterization of the CagL loop segments. The best 
characterized host-directed T4SS translocation systems include the ones from A. tumefaciens (plant-directed21,47), 
Bartonella spp. (mammalian hosts48), and Brucella spp. (mammalian hosts49,50). When analyzing those proposed 
VirB5 proteins, which we modeled using CagL as a template, the A. tumefaciens, Bartonella and Brucella proteins 
possess predicted loop regions between their antiparallel alpha helices (e.g. corresponding to loops 1 and 4 in 
CagL, sequence alignment shown in Supplementary Fig. S2). With regard to our present findings for CagL, those 
specific loop regions (Supplementary Fig. S9) may be instructive for investigating interactions with their respec-
tive target bacterial or host cells.
Taken together, we have characterized three novel categories of functionally important CagL motifs. Two 
types of deletions led to strongly diminished Cag T4SS function, by reducing the amounts of both CagL and CagI: 
one category of motifs located at the edge of helix α 2 (loop 2) likely is important for CagL integrity and stability, 
while the second segment (in loop 3) may be involved in direct CagL-CagI interactions. Most importantly, we 
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have identified two other chromosomal motifs in addition to RGD (TSPSA in loop 1 and TASLI in loop 4) whose 
deletions formed stable variants of CagL and do not abolish CagL expression or proper localization. These two 
motif mutants have only a moderate defect in IL-8 secretion and CagA translocation in human gastric epithelial 
cells after H. pylori coincubation, however the motifs appear to strongly contribute to integrin and cell interac-
tions. For both, TSPSA, and the TASLI motif, structurally opposite RGD, we were able to show for the first time 
that they are involved in CagL integrin interaction. The TSPSA loop is the most strain-variable region in CagL, 
including amino acid deletions, in particular in East Asian strains. We propose that TSPSA is surface-associated 
in CagL and contributes to the positioning of the RGD motif which indirectly affects integrin binding. TASLI 
contributed strongly to CagL integrin binding even independently from RGD, while the absence of TASLI and 
RGD together even enhanced CagL cell binding. Interestingly, only very few other H. pylori proteins contain 
highly conserved TASLI motifs (own unpublished data). Most notably, ImaA (HP0289), an autotransporter pro-
tein and VacA ortholog of H. pylori51, contains one complete and a second, incomplete (ASLI) motif. ImaA was 
previously reported, possibly via competition for host integrin, to compete with the Cag T4SS for cell interaction 
and to reduce cagPAI-mediated cell activation in vitro and in vivo51. In conclusion, variable loop regions of CagL 
exhibit H. pylori-specific, novel T4SS functions. Some are involved in RGD-accessory integrin binding, or in 
possibly integrin-independent host cell interaction. These findings confer the potential to inhibit Cag T4SS func-
tion and may encourage novel approaches to tackle the structural and functional characterization of potential 
orthologs in pathogenic bacteria.
Materials and Methods
Bacterial strains and culture conditions. H. pylori parental strains 2669552, and SU25 were used for 
genetic manipulations, protein analysis and eukaryotic cell infections. The two strains harbour a functional cag 
pathogenicity island (cagPAI) in their genome, encoding the Cag T4SS4,5. H. pylori strains and mutants used in 
this study are listed in Supplementary Table S1. Bacteria were regularly grown on blood agar plates (Oxoid blood 
agar base II, Wesel, Germany) supplemented with 10% (v/v) horse blood and the following antibiotics: ampho-
tericin B (4 mg/liter), polymyxin B (2,500 U/liter), trimethoprim (5 mg/liter) and vancomycin (10 mg/liter). 
Plates were continuously incubated in anaerobic jars under microaerobic atmosphere generated by Anaerocult 
C sachets (Merck, Darmstadt, Germany). Mutant strains were selected and cultivated on blood agar plates mixed 
with chloramphenicol (10 mg/liter) and/or kanamycin (100 mg/liter). E. coli strains DH5α , MC1061, XL1-Blue 
and XL10-Gold were used for cloning experiments (Supplementary Table S1). For the recombinant expression of 
H. pylori CagL, E. coli BL21(DE3) was used. E. coli strains were propagated on Luria Bertani plates or in LB broth 
containing ampicillin (200 mg/liter), chloramphenicol (20 mg/liter) and/or kanamycin (100 mg/liter) as required.
Standard techniques for DNA and protein analysis. Standard procedures for cloning and DNA anal-
ysis were performed according to53. DNA modification and restriction enzymes were purchased from Invitrogen 
(Life Technologies), New England Biolabs (NEB) or Roche. Isolation of highly pure genomic DNA, purification 
of plasmid DNA and gel extraction of DNA from enzymatic reactions were accomplished by QIAGEN DNA puri-
fication columns (QIAGEN, Hilden, Germany). Plasmids and oligonucleotide primers for cloning, sequencing 
and site-directed mutagenesis are depicted in Supplementary Tables S2, S3 and S4, respectively. PCRs were run in 
Biometra thermocyclers (Biometra, Goettingen, Germany) using Taq polymerase (GE Healthcare). Pfu (Agilent 
Technologies) and Phusion (NEB) proofreading polymerases were used for accurate amplification of longer DNA 
fragments. Protein separation and detection by denaturing SDS polyacrylamide gel electrophoresis (SDS PAGE) 
and Western blotting were performed according to standard methods54,55. Total protein concentration was meas-
ured using the bicinchoninic acid (BCA) assay (Thermo Scientific). Protein concentration and purity of recom-
binant proteins were estimated by SDS PAGE and Coomassie or silver staining, comparing the yield to defined 
BSA standards. Protein samples were separated on 10.6% or 11.5% SDS polyacrylamide gels depending on the 
molecular mass of the protein to be analyzed. Subsequently, protein samples were transferred to nitrocellulose 
membranes (Schleicher & Schuell, Germany) by tank blotting. Antisera and antibodies for immunodetection 
were diluted in TBS-T (TBS with 5% skim milk and 0.1% Tween 20) as noted in the figure legends. Secondary 
antibodies were used as conjugates to horseradish peroxidase (HRP). For detection of the HRP signal, mem-
branes were incubated with enhanced chemiluminescent substrate (SuperSignal West Pico, Thermo Scientific) 
and exposed to chemiluminescence films (Amersham HyperfilmTM ECL, GE Healthcare). Before reapplication of 
antibodies, membranes were stripped with RestoreTM Western Blot Stripping Buffer (Thermo Scientific).
Cell fractionation and isolation of H. pylori surface-exposed proteins. Whole cell lysates were 
generated from bacteria grown for 1.5–2 d on blood agar plates and resuspended in Tris/HCl (100 mM, pH 
7.5). Bacteria were sonicated three times for 2 min and the protein content of the lysates was determined. Equal 
amounts of protein for each preparation were separated on SDS gels for comparison. For the quantification of 
CagL, CagI, CagH, and CagA protein amounts, the detected signal intensities from Western blots were scanned 
to TIFF files and analyzed by densitometry using ImageJ56. Protein amounts (band intensities) were normalized 
to invariable bacterial protein bands detected by an anti-H. pylori polyclonal antiserum (DAKO; 1:10,000).
For the subcellular localization of wild type or mutated CagL, bacteria were separated into outer 
(surface-enriched), soluble and insoluble fractions by bacterial shearing, sonification and differential centrif-
ugation. Preparation of the bacterial outer fraction (OF), containing surface-exposed proteins and bacterial 
appendages, was accomplished as previously described19. In brief, cells were grown for 1.5–2 d on blood agar 
plates, resuspended in Tris/HCl (100 mM, pH 7.5) and sheared by pushing the suspension repeatedly (30 times) 
through 26-gauge syringe needles (Braun Sterican® , 0,45 × 25 mm, Braun, Melsungen, Germany) to detach 
surface-exposed material. Intact bacterial cells were separated from the sheared material by repeated differential 
centrifugation steps (21,912× g for 20 min, 186,000× g for 1 h in an Optima CU-TL100 Beckman ultracentrifuge). 
www.nature.com/scientificreports/
1 2Scientific RepoRts | 6:38101 | DOI: 10.1038/srep38101
Remaining bacterial pellets were resuspended again in Tris/HCl (100 mM, pH 7.5), supplemented with Complete 
Mini protease inhibitor cocktail (Roche) and sonicated for 1–2 min at 4 °C (Branson Sonifier 450, setting 5). 
Subsequently, the lysates were separated into soluble (enriched in cytoplasmic and periplasmic material) and 
insoluble fractions (membrane-enriched) by centrifugation (186,000× g, 30 min, 4 °C). The supernatants (solu-
ble fractions) were removed and the pellets, containing the crude membrane (insoluble) fractions, resuspended 
in Tris/HCl (100 mM, pH 7.5, Complete Mini). All prepared fractions were analyzed by Western immunoblot-
ting. CagL running at approximately 26 kDa was detected using α -HP0539 antiserum AK271 (Fig. 2)22. CagI 
was detected at approximately 40 kDa using α -HP0540 antiserum (Fig. 2) that was described previously25. Cell 
fractionations were verified by an antiserum raised against H. pylori FlhA (membrane-bound component of the 
flagellar protein export apparatus) as a fractionation control for the insoluble fraction (Supplementary Fig. S5). 
As a fractionation control for the outer fraction, an antiserum against the H. pylori outer membrane protein HopZ 
was used, which detected HopZ exclusively in the insoluble (membrane-enriched) fractions (data not shown) 
(antiserum polyclonal rabbit α -HopZ/type1, 1:10,000)57,58.
CagL in silico analyses. For the CagL protein secondary and tertiary structure predictions, we used the 
CagL primary sequence from strain 2669552 as query sequence. The CagL signal peptide was predicted by SignalP 
4.159, the secondary structure by JPred3 (incorporating Jnet)60. For the structure-based 3D structural modelling 
of CagL, we used the PHYRE protein homology/analogy recognition engine and database61,62. CagL 2D and 3D 
structural predictions were performed before the first CagL structure was published to define the proposed CagL 
leader peptide segment for cloning purposes, and to instruct the definition of disordered and potentially instable 
regions. In silico predictions were also used throughout the work to assess the potential structural stability of 
protein regions or mutated proteins. For the template-based structural prediction of CagL mutant proteins, we 
used the online structure homology modelling server Swiss Model63.
In order to support the design of single substitution mutants in CagL, we used in silico prediction of local pKa 
of charged amino acid residues. We thereby determined the propensity of K170 in the CagL substitution mutant 
T170K to be locally charged under different conditions, which might be relevant for potential conformational 
change. The local pKa values for all lysine residues of CagL variant T170K were analyzed based on the CagL 
protein structure with DEPTH Server64. The results suggest that all other lysine residues except for “artificial” 
lysine 170 in CagL possess pKa values of around 10 (as expected). For substituted lysine 170, a local pKa of 8.3 is 
proposed by DEPTH. As a second and independent prediction software, H+ + (http://biophysics.cs.vt.edu/index.
php), also based on the CagL structural information, gave a similar output, suggesting a local pKa of 7.3 for K170, 
while all other, natural, lysine residues in CagL have a pKa of around 10. Both applications require a pdb file as 
input and thus take the local environment and solvent accessibility into account. Standard settings were used for 
these predictions, and the CagL T170K model pdb (derived from pdb:3czj_chainA) was supplied. The results 
appear therefore to be reliable and suggest that at physiological pH values (between 7 and 8) in the context of its 
protein environment, the substituted lysine 170 residue may be partially protonated and partially non-protonated.
Recombinant CagL expression, native purification and protein characteristics. To construct a 
plasmid for the heterologous expression of CagL (wild type) in E. coli, oligonucleotide primers HP0539_fw2 
and HP0539_rv2 were used to amplify the cagL coding region from H. pylori 26695 genomic DNA without the 
predicted CagL N-terminal signal sequence (amino acid residues 21–237). The amplified cagL DNA segment was 
ligated in-frame at EcoRI and NotI sites into the pGEX-4T-2 expression vector (GE Healthcare) yielding plasmid 
pCJ905. This plasmid expresses a fusion protein with an N-terminal GST tag. The nucleotide sequence of the cagL 
coding region in pCJ905 was verified by PCR and Sanger sequencing. For the heterologous expression of mutated 
CagL motif variants, plasmids were constructed analogously with the mutated sequence.
For expression cultures, 200 ml Luria broth were inoculated with an overnight culture of E. coli BL21(DE3) 
transformed with the respective plasmid (Supplementary Table S2). Bacteria were grown in a shaking incubator 
at 150 rpm, 30 °C. CagL expression was initiated at an OD600 of 0.6 by the addition of 0.2 mM IPTG. Growth of the 
cultures was continued for four additional hours. Bacteria were harvested by centrifugation (6,000× g, 10 min).
Purification of GST-tagged proteins was performed as follows: In brief, bacterial cell pellets were resus-
pended in ice-cold PBS (Dulbecco) supplemented with protease inhibitor cocktail (Roche). Crude lysates were 
separated by sonication and amounts analysed by SDS gels and Coomassie staining. GST fusion proteins, pre-
dominantly located in the insoluble fraction, were solubilized in buffer S (PBS Dulbecco, 2 mM DTT, 1 mM 
EDTA, 0.5% sarkosyl, 0.7% Triton X-100, protease inhibitor cocktail, Roche) and clarified by centrifugation 
to remove insoluble cellular debris. The solubilized protein fraction was loaded onto equilibrated glutathione 
agarose columns (Protino® GST/4B, Macherey Nagel, Germany). Subsequently to the binding, the column was 
washed with buffer W (PBS Dulbecco, 2 mM DTT, 1 mM EDTA, 0.1% Triton X-100, protease inhibitor cocktail, 
Roche). Bound GST fusion proteins were eluted in buffer E (100 mM Tris-HCl, pH = 8, 150 mM NaCl, 1 mM 
DTT, 10 mM reduced L-glutathione). For further downstream applications, the GST tag was cleaved off using 
thrombin protease (GE Healthcare) cleavage. The cleaved GST tag was removed by passing the pure proteins 
for a second time through a glutathione agarose column in buffer E without glutathione and collecting the pure, 
cleaved CagL proteins in the flow-through, while the GST stayed bound to the column. The purity of CagL 
after GST cleavage was then assessed on a Western blot, which was subsequently detected using anti-CagL and 
anti-GST antisera (Supplementary Figure S8 panel C). Prior to use, pure proteins were concentrated in 100 mM 
Tris-HCl, pH = 8, 150 mM NaCl, 1 mM DTT using centrifugal filter units (Amicon Ultra-15, Merck Millipore). 
The amounts of CagL for binding assays were carefully adjusted in ng quantities on repeated SDS gels with sil-
ver staining and respective BSA controls (See Supplementary Fig. S8). Uniform detection of each motif-deleted 
CagL variant with the polyclonal antiserum AK271 was verified using Western blotting of equal CagL amounts 
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(Supplementary Fig. S8, panel C), and using also an ELISA like-setup, testing different CagL amounts of each 
variant in comparison.
Construction of isogenic chromosomal unmarked mutants in H. pylori cagL. Plasmid constructs 
for the generation of isogenic chromosomal unmarked H. pylori SU2 cagL mutants (by allelic exchange) were 
propagated in E. coli. Plasmid manipulations by means of site-directed mutagenesis (SDM) were performed by 
inverse PCR using mutagenic primers or the QuikChange® Site-Directed Mutagenesis Kit (Stratagene), using plas-
mid pCJ450 (Supplementary Table S2) as a template for mutagenesis. Plasmids obtained after CagL SDM are also 
summarized in Supplementary Table S2. Primers used for the SDM are listed in Supplementary Table S3; primers 
designed for the verification of mutant alleles by Sanger sequencing are contained in Supplementary Table S4. We 
introduced these unmarked mutations into the chromosomal copy of the H. pylori cagL gene (HP0539 from strain 
26695) by using a sucrose-based counterselection system65. In brief, an aphA3′ -III-sacB cassette was inserted 
into the cagL gene of strain H. pylori SU2 by homologous recombination (plasmid pCJ 474). Subsequent trans-
formation with different mutated cagL alleles (plasmids listed in Supplementary Table S2) and counterselective 
growth on sucrose-supplemented blood plates enabled the selection of strains that had exchanged the aphA3′ 
-III-sacB cassette for the unmarked mutated allele. All SDM plasmids and the cagL alleles of the resulting mutated 
H. pylori clones were sequenced using Sanger sequencing to verify that the correct mutations and deletions had 
been obtained.
cagL allelic exchange mutant in H. pylori. For the functional characterization of CagL and poten-
tial bacterial interacting proteins, an insertion mutant in the cagL gene (HP0539 from strain 26695) was con-
structed by partial gene deletion and insertion of an antibiotic resistance cassette, followed by allelic exchange in 
H. pylori. Plasmid constructs were generated in E. coli. For the construction of a HP0539/cagL knockout mutant 
and further site-directed mutagenesis of selected regions, HP0539/cagL, HP0540/cagI and the C-terminal part 
of HP0541/cagH were amplified from strain 26695 using primers HP0541_F1 and HP0538_R1 and cloned into 
pUC18. The resulting plasmid (pCJ450) was inversely amplified using primers HP0539_F1 and HP0539_R1 and 
ligated at BamHI sites with a kanamycin resistance cassette (aphA3′ -III from Campylobacter coli from plasmid 
pILL60066, yielding pCJ451. In order to avoid polar effects, the resistance cassette was inserted in the same orien-
tation as the target gene. Orientation of the aphA3′ -III cassette was verified by PCR using different combinations 
of oligonucleotide primers (HP0541_F1 and Km1, HP0541_F1 and Km2, HP0538_R1 and Km1, HP0538_R1 and 
Km2) and targeted Sanger sequencing (sequencing primers available on request). Plasmids for mutagenesis and 
primers for cloning are listed in Supplementary Tables S2 and S4.
Cell coculture experiments with H. pylori and quantification of chemokine secretion. For func-
tional studies, H. pylori wt strains and cagL mutants were cocultured with the human gastric adenocarcinoma cell 
line AGS (ATCC® CRL-1739TM). Cells were grown in RPMI 1640 supplemented with 10% fetal bovine serum 
(FBS) buffered with 25 mM HEPES (Biochrom, Berlin, Germany). Cell infection experiments were performed on 
subconfluent cell layers (60% to 90% confluence) in 24 well plates. Cells were preincubated in fresh medium with 
FBS 60 min prior to infection. Exponentially growing bacteria were harvested from blood plates and resuspended 
in RPMI 1640 (RPMI 1640, 10% FBS, 25 mM HEPES). AGS cells were infected with H. pylori at a multiplicity 
of infection (MOI) of 50. The infection was synchronized by centrifugation of the incubation plates (154× g, 
10 min, 20 °C). The co-incubation time was fixed to 22 h. Non-infected cells (mock) were used as negative con-
trol. Supernatants were harvested, cleared by centrifugation (21,912× g, 10 min, 4 °C) and stored at − 20 °C until 
further use. IL-8 secretion by AGS cells into the cell supernatant in response to H. pylori contact was monitored 
by using an anti-human IL-8 sandwich ELISA (BD OptEIA IL-8 enzyme-linked immunosorbent assay kit, BD 
Pharmingen, San Diego, USA) according to the manufacturer’s instructions, using appropriate dilutions. The IL-8 
assays were performed in triplicate for each sample, and the cell coincubations were performed at least four times 
independently on different days, each time either in duplicate or triplicate infection wells. Means and standard 
deviations of at least four independent co-incubations measured in triplicates were calculated. The level of IL-8 
secretion induced by contact with H. pylori SU2 wt was set to 100% and was compared to levels secreted by AGS 
cells after coincubation with cagL insertion mutants.
CagA translocation assay. Translocation of the CagA effector protein into cells was examined by cocul-
turing H. pylori strains with AGS cells. To analyse CagA translocation, AGS cells were grown in 6-well plates and 
infected with H. pylori at a multiplicity of infection (MOI) of 100 for 4 h. Non-adherent bacteria were removed 
by washing twice with PBS Dulbecco (pH = 7.4, Biochrom, Berlin, Germany). Cells were detached using a cell 
scraper and resuspended in 500 μ l PBS. After centrifugation (250× g, 10 min, 4 °C) cells were lysed in 300 μ l of 
modified RIPA lysis buffer (20 mM Tris-HCl [pH = 7.5], 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton 
X-100, 2.5 mM sodium pyrophosphate, 1 mM β -glycerol phosphate, 1 mM sodium orthovanadate, 1 mM PMSF) 
supplemented with Complete Mini protease inhibitor cocktail (Roche) and PhosSTOP phosphatase inhibitor 
(Roche). During lysis, cells were placed on ice for 30 min. Cell debris was cleared by centrifugation (21,912× g, 
10 min, 4 °C). The supernatant was transferred into a fresh tube. The pellet was resuspended in 100 μ l RIPA lysis 
buffer. Both fractions were stored at − 80 °C until use.
CagA translocation was evaluated by separating the soluble fractions on 10.6% SDS-PAGE (20 μ g loaded 
per lane) and immunoblotting with an affinity-purified anti-phospho-peptide antibody (rabbit anti-Hp-pCagA, 
1:10,000), raised against a CagA C-terminal peptide sequence CSPEPI-pY-ATID (Biosyntan, Berlin) detecting 
phosphorylated CagA (pCagA). Subsequently, total CagA protein (phosphorylated and non-phosphorylated 
CagA) was detected using a polyclonal α -CagA antiserum (rabbit α -Hp-CagA-antigen, IgG-fraction, Austral 
Biologicals, San Ramon, USA, 1:10,000). As a bacterial loading control, heat-stable H. pylori antigens (rabbit 
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α -H. pylori, DAKO, Denmark, 1:2,500) were detected in the analyzed fractions; as a cellular loading control, we 
detected actin (mouse α -actin, Millipore, Schwalbach, Germany, 1:20,000). For the quantification of the pCagA 
protein amount, the detected signals were scanned to TIFF files (600 dpi resolution) and analysed by densitom-
etry using ImageJ56. pTyr CagA (translocated CagA) was normalized for each sample as follows: First, the meas-
ured intensities of CagA signals in each lane were normalised by multiplication with a correction factor that was 
determined separately for each sample using the H. pylori invariable protein loading control (detected by rabbit 
α -H. pylori, DAKO, Denmark, 1:2,500). Secondly, the pTyr-CagA values in each lane were corrected using the 
normalized CagA values as percent of the respective normalized CagA positive control. Background values from 
the same blot comprising the same pixel numbers were subtracted from each positive band. CagA translocation 
assays were at least performed twice independently on different days for two clones of each mutant.
CagL integrin binding test in multiwell plates. For the determination of the binding of CagL to one of 
its putative host cell receptors, integrin α 5β 1, purified proteins were analysed in a modified ELISA-like setup. CagL 
amounts for the different proteins were carefully adjusted and equalized by running multiple Coomassie-stained 
and silver-stained SDS gels (Supplementary Fig. S8), along with lanes loaded with an upltrapure standard pro-
tein (bovine serum albumin [BSA, Sigma-Aldrich] or glutathione-S-transferase [GST, Sigma-Aldrich]) in known 
concentrations. Briefly, wells were coated overnight with 100 ng/well of recombinant human integrin α 5β 1 or 
related integrins (α Vβ 5, α Vβ 6) (R&D Systems, Wiesbaden, Germany) diluted in coating buffer (100 mM sodium 
carbonate, pH = 9.5). Wells were blocked with either FCS-containing blocking buffer (FB) (10% FCS in PBS 
Dulbecco) or FCS-free blocker (FFB) (PBS Dulbecco, 0.2% Tween®20, 0.1% glycine). Subsequently, increas-
ing amounts (2.5, 5, 10 and 20 ng/well) of recombinant CagL protein were added to also determine possible 
concentration-dependent effects on binding. As mock controls, wells were co-incubated with FB/FFB without 
CagL protein and with antiserum. As a further control, empty wells after blocking were incubated with CagL 
variants and antiserum to detect background attachment of CagL to the wells. This control was always lower 
than the mock control. The co-incubation time was fixed to 3 h. Wells were aspirated and washed repeatedly. For 
the detection of bound CagL, wells were incubated with α -CagL antiserum AK271 (1:10,000) and the respective 
HRP-conjugated secondary antibodies (1:25,000). For the detection of integrin α 5β 1 (control wells) wells were 
incubated with α -integrin β 1-specific IgG (R&D Systems, Wiesbaden, Germany) and corresponding secondary 
antibodies. In some assays, collagen IV (Sigma-Aldrich) was added in the first three incubation steps, in com-
bination with FFB. After substrate development (BD OptEIATM TMB substrate reagent set, BD Pharmingen, 
San Diego, USA), absorbance was read at 450 nm and 540 nm (reference wavelength) in a Titertek Multiskan® 
MCC/340 fluorometer. CagL integrin binding assays were performed in technical duplicates or triplicates, at 
least three times for each mutant protein on different days. The normalization was performed after background 
subtraction by setting the values of the respective CagL wild type protein control to 100% and calculating relative 
values in percent for the respective mutant proteins (ratio of wild type CagL signal to negative background was 
between 8 to 10 for all experiments).
CagL cell binding assays. To monitor the binding of purified CagL protein to AGS cells, CagL proteins 
were analyzed in an ELISA-like setup. CagL amounts for the different proteins were carefully adjusted and equal-
ized by running multiple Coomassie-stained and silver-stained SDS gels, along with lanes loaded with an internal 
protein standard (GST or BSA) in known concentrations. Briefly, AGS cells were grown to confluence in 96 well 
plates (6 × 104 cells/well) and fixed with paraformaldehyde (2% PFA in 100 mM potassium phosphate buffer, 
pH = 7). Fixing would prevent uptake and degradation of CagL by the cells. Cell fixation was stopped by the 
addition of quenching buffer (0.1% glycine in PBS). Fixed cells were washed repeatedly with PBS and blocked 
with FCS blocking buffer (FB) (10% FCS in PBS Dulbecco) or FCS-free blocker (FFB) (PBS Dulbecco, Roti-Block 
x0.2 [Carl Roth] 0.2% Tween®20, 0.1% glycine). Subsequently, recombinant CagL protein was added in increasing 
amounts (2.5, 5, 10 and 20 ng/well) to determine possible concentration-dependent effects on binding.
As mock controls, wells were co-incubated with FB/FFB without CagL protein. The co-incubation time was 
fixed to 3 h. To remove unbound protein, cells were washed with ELISA washing buffer (PBS + 0.05% Tween 
20). For the detection of bound CagL, wells were incubated with α -HP0539 antiserum AK271 (1:10,000) over-
night followed by incubation with the respective HRP-conjugated secondary antibodies (1:25,000). Substrate (BD 
OptEIATM TMB substrate reagent set, BD Pharmingen, San Diego, USA) and stop solution (1 M phosphoric acid) 
were added to the wells. Samples were transferred to a new 96 well plate and absorbance was read at 450 nm and 
540 nm (reference wavelength) in a Titertek Multiskan® MCC/340 fluorometer. CagL cell binding assays were 
performed in technical duplicates, at least three times for each mutant protein on different days. Normalization 
and calculation of relative values were done as for the integrin binding.
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